Inventors with similar research interests:
Location History:
- Zama, JP (1986)
- Yokohama, JP (2002)
- Tokyo, JP (1985 - 2019)
- Kanagawa, JP (1990 - 2022)
- Fujisawa, JP (2020 - 2023)
Company Filing History:
29 out of 1,179 
17 out of 39 
6 out of 58,131 
Years Active: 1985-2023
Areas of Expertise:
Title: Minoru Nakamura: Pioneering Innovations in Neuropharmacology
Introduction
Minoru Nakamura, located in Kanagawa, Japan, is a prolific inventor with an impressive total of 65 patents to his name. His work primarily focuses on developing novel chemical compounds that have significant therapeutic potential, particularly in the field of neuropharmacology. Nakamura's contributions to medical science have paved the way for advancements in the treatment of various neurological disorders.
Latest Patents
Among his latest innovations, Nakamura has received patents for two notable inventions related to heterocyclic NMDA antagonists. The first patent describes a compound that may exhibit antagonistic action against NMDA receptors containing the NR2B subunit. This compound shows promise for use as a prophylactic or therapeutic agent for conditions such as depression, bipolar disorder, migraines, pain related to dementia, and other similar symptoms. The second patent expands on this work, providing details on a heterocyclic compound that also targets the NR2B subunit, expected to be an effective treatment option for major depression, bipolar disorder, and the behavioral and psychological symptoms associated with dementia.
Career Highlights
Nakamura's career is marked by his impactful collaborations with distinguished companies in the pharmaceutical industry. Notably, he has worked with Takeda Pharmaceutical Company Limited, a leader in global pharmaceutical innovation, and Hitec Co., Ltd., which specializes in advanced technology solutions. His work in these organizations has allowed him to contribute significantly to scientific advancements in drug development.
Collaborations
Throughout his career, Nakamura has collaborated with esteemed colleagues such as Makoto Kamata and Masami Yamada. These collaborations have fostered an environment of innovation and discovery, enhancing the potential for breakthroughs in treating neurological disorders through targeted pharmacological strategies.
Conclusion
Minoru Nakamura's contributions to the field of neuropharmacology are invaluable. With a strong patent portfolio and a dedication to addressing significant medical challenges, his work continues to influence the landscape of treatment options for various mental health and neurological conditions. His innovative approaches ensure that he remains at the forefront of scientific advancements in this critical area of health care.